Huxin Formula

Developed for: acute coronary syndrome · coronary artery intramyocardial course
Investigated by: Beijing Anzhen Hospital · Beijing Tongren Hospital · China-Japan Friendship Hospital · First Affiliated Hospital, Sun Yat-Sen University · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Gansu Provincial Hospital
+13 more
· Guangdong Provincial People's Hospital · Guangzhou Overseas Chinese Hospital · Guangzhou University of Chinese Medicine · Liaoning University of Traditional Chinese Medicine · PLA.The Military General Hospital of Beijing · Second People's Hospital, Fujian Province · Shaanxi Provincial People's Hospital · Shanghai 10th People's Hospital · Teaching Hospital of Nanjin University of Traditional Chinese Medicine · The Fifth Affliated Hospital of Guangxi Medical University · The Sixth Affliated Hospital of Jinan University · Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region · Xiyuan Hospital of China Academy of Chinese Medical Sciences

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT00965471	Oct 2006 → Oct 2008	acute coronary syndrome, coronary artery intramyocardial course	Guangzhou University of Chinese Medicine	Completed	Missed primary

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Huxin Formula	“CABG patients in the control group were treated with placebo, while patients in the experimental group were treated with Huxin Formula 1 week after the surgery.” PMID 25592946 ↗ Dec 2014